| Vol. 8.44 – 10 November, 2020 |
| |
|
|
| Scientists demonstrated increased expression of lymphotoxin β-receptor (LTβR) ligands in adaptive and innate immune cells, enhanced non-canonical NF-κB signaling, and enriched LTβR target gene expression in lung epithelial cells from patients with smoking-associated chronic obstructive pulmonary disease. [Nature] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators found nicotinamide phosphoribosyltransferase, the rate-limiting enzyme of the NAD+ biogenesis, drove interferon γ-induced PD-L1 expression in multiple types of tumors and governed tumor immune evasion in a CD8+ T cell-dependent manner. [Cell Metabolism] |
|
|
|
| Scientists investigated the humoral immune correlates of protection from cytomegalovirus (CMV) acquisition in populations of CMV-seronegative adolescent and postpartum women who received the gB/MF59 vaccine. [Science Translational Medicine] |
|
|
|
| Researchers report a retrospective exploratory analysis of the trial to evaluate whether co-administration of an unconjugated antibody could improve the intratumoral distribution of the antibody-dye conjugate in patients. [Nature Communications] |
|
|
|
| The authors explored the effects of pelareorep on autophagy in multiple models of colorectal cancer, including patient derived PBMC. [Clinical Cancer Research] |
|
|
|
| Investigators measured three novel cerebrospinal fluid p‐tau biomarkers, phosphorylated at threonine‐181 and threonine‐217 with an N‐terminal partner antibody and at threonine‐231 with a mid‐region partner antibody. [EMBO Molecular Medicine] |
|
|
|
| Researchers identified diverse cell types within the tumor microenvironment in which myeloid cells and T cells were the most abundant stromal cell types in tumors and adjacent lung tissues. [Oncogene] |
|
|
|
| Scientists investigated the potential correlation between clinical outcomes and peripheral blood immune cell profiles, specifically focused on FoxP3+ Treg cells, collected at baseline and one week after anti-PD-1 therapy in two independent cohorts of patients with NSCLC. [Scientific Reports] |
|
|
|
| Researchers provided evidence that genetic pathways involved in progression from islet autoimmunity differ from those pathways identified once disease has been established. [Scientific Reports] |
|
|
|
|
| Our understanding of glucocorticoid (GC) effects on immunity comes largely from administration of exogenous GCs to treat immune or inflammatory disorders. However, it is increasingly clear that endogenous GCs both promote and suppress T cell immunity. [Nature Reviews Immunology] |
|
|
|
| The alternative functionality of oligodendroglia not only regulates immune cell responses, but also hinders remyelination, and might thereby be key to understanding MS disease pathology and promoting regeneration after immune-mediated demyelination. [Seminars in Cell & Developmental Biology] |
|
|
|
|
| XNK Therapeutics AB announced it has received Orphan Drug Designation from the FDA for its leading investigational drug candidate in the treatment of multiple myeloma. [XNK Therapeutics AB] |
|
|
|
| Intellia Therapeutics, Inc. announced that the first patient has been treated with NTLA-2001, which the company is developing as a single-course, potentially curative therapy for transthyretin amyloidosis. [Intellia Therapeutics, Inc.] |
|
|
|
|
| April 9 – April 14, 2021 Washington, DC, United States |
|
|
|
|
|
| Queen’s University – Kingston, Ontario, Canada |
|
|
|
| MRC Laboratory of Molecular Biology – Cambridge, England, United Kingdom |
|
|
|
| Genentech, Inc. – South San Francisco, California, United States |
|
|
|
| LMU University Hospital Munich – Munich, Germany |
|
|
|
| H. Lee Moffitt Cancer Center & Research Institute – Tampa, Florida, United States |
|
|
|
|